ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 219 filers reported holding ISHARES TR in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,231,750 | -3.9% | 22,568 | -2.0% | 0.04% | -2.3% |
Q2 2023 | $2,321,496 | -37.5% | 23,033 | -37.0% | 0.04% | -41.9% |
Q1 2023 | $3,716,283 | -12.3% | 36,556 | -10.1% | 0.07% | -16.9% |
Q4 2022 | $4,237,982 | +2.8% | 40,656 | -9.9% | 0.09% | -4.3% |
Q3 2022 | $4,121,000 | +5.2% | 45,147 | +15.7% | 0.09% | +12.0% |
Q2 2022 | $3,919,000 | +21.9% | 39,024 | +29.8% | 0.08% | +45.6% |
Q1 2022 | $3,215,000 | +5.9% | 30,072 | 0.0% | 0.06% | +16.3% |
Q4 2021 | $3,037,000 | +6.6% | 30,072 | -0.5% | 0.05% | -5.8% |
Q3 2021 | $2,849,000 | -13.1% | 30,222 | -11.0% | 0.05% | -13.3% |
Q2 2021 | $3,280,000 | -1.7% | 33,972 | -3.4% | 0.06% | -9.1% |
Q1 2021 | $3,337,000 | +60.4% | 35,172 | +48.2% | 0.07% | +46.7% |
Q4 2020 | $2,081,000 | +21.9% | 23,727 | +11.9% | 0.04% | +7.1% |
Q3 2020 | $1,707,000 | -8.6% | 21,207 | -7.9% | 0.04% | -16.0% |
Q2 2020 | $1,868,000 | +93.8% | 23,021 | +70.9% | 0.05% | +56.2% |
Q1 2020 | $964,000 | +132.3% | 13,471 | +218.8% | 0.03% | +190.9% |
Q4 2019 | $415,000 | +4.3% | 4,226 | 0.0% | 0.01% | -8.3% |
Q3 2019 | $398,000 | +27.2% | 4,226 | +27.3% | 0.01% | +20.0% |
Q2 2019 | $313,000 | +18.6% | 3,319 | +17.1% | 0.01% | +11.1% |
Q1 2019 | $264,000 | +21.1% | 2,834 | +9.7% | 0.01% | +12.5% |
Q4 2018 | $218,000 | -83.8% | 2,584 | -84.4% | 0.01% | -85.7% |
Q3 2016 | $1,349,000 | -1.1% | 16,600 | 0.0% | 0.06% | -6.7% |
Q2 2016 | $1,364,000 | -47.7% | 16,600 | -50.3% | 0.06% | -47.8% |
Q1 2016 | $2,608,000 | +6.3% | 33,432 | 0.0% | 0.12% | +0.9% |
Q4 2015 | $2,454,000 | +5.5% | 33,432 | 0.0% | 0.11% | +2.7% |
Q3 2015 | $2,326,000 | -5.4% | 33,432 | 0.0% | 0.11% | 0.0% |
Q2 2015 | $2,460,000 | -1.9% | 33,432 | 0.0% | 0.11% | -3.5% |
Q1 2015 | $2,508,000 | -0.3% | 33,432 | 0.0% | 0.12% | -8.7% |
Q3 2014 | $2,515,000 | -10.8% | 33,432 | -10.6% | 0.13% | -13.1% |
Q2 2014 | $2,819,000 | -9.4% | 37,400 | -14.1% | 0.14% | -17.1% |
Q1 2014 | $3,112,000 | +1.7% | 43,550 | 0.0% | 0.18% | +4.2% |
Q4 2013 | $3,059,000 | +6.0% | 43,550 | 0.0% | 0.17% | +1.8% |
Q3 2013 | $2,886,000 | -16.2% | 43,550 | -16.1% | 0.16% | -15.4% |
Q2 2013 | $3,442,000 | – | 51,885 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
MCIA Inc | 182,506 | $18,400,000 | 9.20% |
Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |